Abstract

Fluoxetine Hydrochloride 1-mg/mL Oral Liquid

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2007 - Pediatric Patients

Page(s): 73

Download in electronic PDF format for $75

Abstract

A formulation for preparing Fluoxetine Hydrochloride 1-mg/mL Oral Liquid. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2007 Pg. 73	Fluoxetine Hydrochloride 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 2017 Pg. 242-246	Absorption of Transdermal Fluoxetine Compounded in a Lipoderm Base Compared to Oral Fluoxetine in Client-owned Cats Author(s): Eichstadt Lauren R, Corriveau Lorraine A, Moore George E, Knipp Gregory T, Cooper Bruce R, Gwin Wilson E
Sep/Oct 2018 Pg. 409	Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 516-526	Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Author(s): Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Nov/Dec 2006 Pg. 418	Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety Author(s): Fields Shannon W
Jul/Aug 2001 Pg. 310-312	Wetting and/or Solubilizing Agents, Featured Excipient: Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 457	Hydralazine Hydrochloride 1-mg/mL or 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 253-255	Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Author(s): Peacock Gina F, Sauvageot Jurgita
Nov/Dec 2006 Pg. 452	Amiloride Hydrochloride 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 304	Propranolol Hydrochloride 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 480-488	A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing Author(s): Riepl Mike
Jul/Aug 2023 Pg. 329	Trihexyphenidyl Hydrochloride 1-mg/mL Oral Liquid, Alcohol-free Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 481	Valganciclovir Hydrochloride 60-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2006 Pg. 146	Trazodone Hydrochloride 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 308	Tramadol Hydrochloride 7.5-mg/mL and Acetaminophen 65-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 318	Sertraline Hydrochloride 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 327-336	Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4 Author(s): Espana B, Joseph-Tornabène F, Jaquet Cécile, Perrot S, Prouillac C
Jul/Aug 2006 Pg. 307	Tramadol Hydrochloride 5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr